Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313398972> ?p ?o ?g. }
- W4313398972 endingPage "520" @default.
- W4313398972 startingPage "503" @default.
- W4313398972 abstract "Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after surgery, but less data exist for patients treated with definitive radiation therapy (RT) or RT in oligo-/metastatic disease stages. To guide future perspectives of GCs for RT, we conducted (1) a systematic review on the evidence of GCs for patients treated with RT and (2) a survey of experts using the Delphi method, addressing the role of GCs in personalized treatments to identify relevant fields of future clinical and translational research. We performed a systematic review and screened ongoing clinical trials on ClinicalTrials.gov. Based on these results, a multidisciplinary international team of experts received an adapted Delphi method survey. Thirty-one and 30 experts answered round 1 and round 2, respectively. Questions with ≥75% agreement were considered relevant and included in the qualitative synthesis. Evidence for GCs as predictive biomarkers is mainly available to the postoperative RT setting. Validation of GCs as prognostic markers in the definitive RT setting is emerging. Experts used GCs in patients with PCa with extensive metastases (30%), in postoperative settings (27%), and in newly diagnosed PCa (23%). Forty-seven percent of experts do not currently use GCs in clinical practice. Expert consensus demonstrates that GCs are promising tools to improve risk-stratification in primary and oligo-/metastatic patients in addition to existing classifications. Experts were convinced that GCs might guide treatment decisions in terms of RT-field definition and intensification/deintensification in various disease stages. This work confirms the value of GCs and the promising evidence of GC utility in the setting of RT. Additional studies of GCs as prognostic biomarkers are anticipated and form the basis for future studies addressing predictive capabilities of GCs to optimize RT and systemic therapy. The expert consensus points out future directions for GC research in the management of PCa." @default.
- W4313398972 created "2023-01-06" @default.
- W4313398972 creator A5006322525 @default.
- W4313398972 creator A5010916774 @default.
- W4313398972 creator A5011133286 @default.
- W4313398972 creator A5011183093 @default.
- W4313398972 creator A5014582211 @default.
- W4313398972 creator A5015363712 @default.
- W4313398972 creator A5017091430 @default.
- W4313398972 creator A5020162911 @default.
- W4313398972 creator A5020556055 @default.
- W4313398972 creator A5026826746 @default.
- W4313398972 creator A5028333961 @default.
- W4313398972 creator A5030545703 @default.
- W4313398972 creator A5038906134 @default.
- W4313398972 creator A5039646183 @default.
- W4313398972 creator A5041059810 @default.
- W4313398972 creator A5043242910 @default.
- W4313398972 creator A5045688922 @default.
- W4313398972 creator A5045794019 @default.
- W4313398972 creator A5045885487 @default.
- W4313398972 creator A5049692975 @default.
- W4313398972 creator A5053706672 @default.
- W4313398972 creator A5055958896 @default.
- W4313398972 creator A5056302482 @default.
- W4313398972 creator A5057612450 @default.
- W4313398972 creator A5057847756 @default.
- W4313398972 creator A5059094150 @default.
- W4313398972 creator A5059687476 @default.
- W4313398972 creator A5062227791 @default.
- W4313398972 creator A5065439229 @default.
- W4313398972 creator A5070623757 @default.
- W4313398972 creator A5074419565 @default.
- W4313398972 creator A5074537923 @default.
- W4313398972 creator A5076238068 @default.
- W4313398972 creator A5077141876 @default.
- W4313398972 creator A5077868708 @default.
- W4313398972 creator A5085968028 @default.
- W4313398972 creator A5087189944 @default.
- W4313398972 creator A5087640025 @default.
- W4313398972 creator A5089674017 @default.
- W4313398972 creator A5091210921 @default.
- W4313398972 date "2023-07-01" @default.
- W4313398972 modified "2023-09-28" @default.
- W4313398972 title "Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus" @default.
- W4313398972 cites W1554670498 @default.
- W4313398972 cites W1888052965 @default.
- W4313398972 cites W2005501262 @default.
- W4313398972 cites W2009101549 @default.
- W4313398972 cites W2048088264 @default.
- W4313398972 cites W2097371198 @default.
- W4313398972 cites W2106556127 @default.
- W4313398972 cites W2114909008 @default.
- W4313398972 cites W2158099560 @default.
- W4313398972 cites W2195297470 @default.
- W4313398972 cites W2345560358 @default.
- W4313398972 cites W2419633645 @default.
- W4313398972 cites W2419885435 @default.
- W4313398972 cites W2433260735 @default.
- W4313398972 cites W2465092116 @default.
- W4313398972 cites W2522935852 @default.
- W4313398972 cites W2530874255 @default.
- W4313398972 cites W2553678345 @default.
- W4313398972 cites W2582799849 @default.
- W4313398972 cites W2598716793 @default.
- W4313398972 cites W2601353955 @default.
- W4313398972 cites W2606048818 @default.
- W4313398972 cites W2613162682 @default.
- W4313398972 cites W2615697870 @default.
- W4313398972 cites W2724482903 @default.
- W4313398972 cites W2743412658 @default.
- W4313398972 cites W2788459110 @default.
- W4313398972 cites W2889201576 @default.
- W4313398972 cites W2910056648 @default.
- W4313398972 cites W2936995645 @default.
- W4313398972 cites W2952903287 @default.
- W4313398972 cites W2973514824 @default.
- W4313398972 cites W2988688765 @default.
- W4313398972 cites W2990455595 @default.
- W4313398972 cites W2995242987 @default.
- W4313398972 cites W3000400923 @default.
- W4313398972 cites W3002858853 @default.
- W4313398972 cites W3012827461 @default.
- W4313398972 cites W3013251573 @default.
- W4313398972 cites W3013252558 @default.
- W4313398972 cites W3014088197 @default.
- W4313398972 cites W3027025155 @default.
- W4313398972 cites W3043638674 @default.
- W4313398972 cites W3088633614 @default.
- W4313398972 cites W3092635944 @default.
- W4313398972 cites W3094935795 @default.
- W4313398972 cites W3097158220 @default.
- W4313398972 cites W3110773361 @default.
- W4313398972 cites W3113153998 @default.
- W4313398972 cites W3125222626 @default.
- W4313398972 cites W3125743225 @default.
- W4313398972 cites W3128646645 @default.
- W4313398972 cites W3128740038 @default.